Online tool encourages families to bone up on genetics

Decision-Making Capacity: The Ethical Core of Patient-Centered Oncology

Researchers have observed that HSC–derived innate lymphoid cells prevent GVHD by inducing interleukin 9 driven T-cell senescence.

Daniel C. McFarland, DO;Louis P. Voigt, MD;Yesne Alici, MD

Immune Priming Strategies Numerically Improve PFS in Ovarian Cancer

Daniel C. McFarland, DO, is joined by Louis P. Voigt, MD, and Yesne Alici, MD, who focused on decision-making capacity and patient-centered care.

Although both immune priming strategies numerically improved ORR and PFS vs olaparib monotherapy, the study was not powered for comparisons between arms.

Roman Fabbricatore

How Can Chlorotoxin-Directed CAR T-Cell Therapy Impact Glioblastoma Care?

Although both immune priming strategies numerically improved ORR and PFS vs olaparib monotherapy, the study was not powered for comparisons between arms.

Michael Barish, PhD

November 17th 2025

Darolutamide/ADT Improves Efficacy in Older Metastatic HSPC Population

Michael Barish, PhD, discusses a novel cellular therapy for patients with glioblastoma that harnesses chlorotoxin, a peptide found in scorpion venom.

Subgroup data from the ARASENS trial support darolutamide plus androgen deprivation therapy as a standard of care in metastatic HSPC regardless of age.

MCS-8, a Plant-Derived Drug, Reduces Prostate Cancer Incidence vs Placebo

Subgroup data from the ARASENS trial support darolutamide plus androgen deprivation therapy as a standard of care in metastatic HSPC regardless of age.

Treatment with MCS-8 yielded no serious adverse effects among patients at a high risk of developing prostate cancer.

Innate lymphoid cells prevent graft-versus-host disease via IL-9-driven T-cell senescence

Treatment with MCS-8 yielded no serious adverse effects among patients at a high risk of developing prostate cancer.

Related Content

American Society for Transplantation and Cellular Therapy

Decision-Making Capacity: The Ethical Core of Patient-Centered Oncology

Researchers have observed that HSC–derived innate lymphoid cells prevent GVHD by inducing interleukin 9 driven T-cell senescence.

Daniel C. McFarland, DO;Louis P. Voigt, MD;Yesne Alici, MD

Immune Priming Strategies Numerically Improve PFS in Ovarian Cancer

Daniel C. McFarland, DO, is joined by Louis P. Voigt, MD, and Yesne Alici, MD, who focused on decision-making capacity and patient-centered care.

Roman Fabbricatore

How Can Chlorotoxin-Directed CAR T-Cell Therapy Impact Glioblastoma Care?

Although both immune priming strategies numerically improved ORR and PFS vs olaparib monotherapy, the study was not powered for comparisons between arms.

Michael Barish, PhD

November 17th 2025

Darolutamide/ADT Improves Efficacy in Older Metastatic HSPC Population

Michael Barish, PhD, discusses a novel cellular therapy for patients with glioblastoma that harnesses chlorotoxin, a peptide found in scorpion venom.

MCS-8, a Plant-Derived Drug, Reduces Prostate Cancer Incidence vs Placebo

Subgroup data from the ARASENS trial support darolutamide plus androgen deprivation therapy as a standard of care in metastatic HSPC regardless of age.